Researchers have found in a new study that oral anticoagulants OAC-naive patients experienced a smaller increase in stroke or systemic embolism with asundexian compared to apixaban. However, this ...

Less Severe Strokes With LAA Closure vs DOAC in AF? Atrial fibrillation treated with left atrial appendage closure was associated with ischemic strokes that were less severe than those among ...

Xabi Alonso has been heavily linked with a move to Real Madrid for a while. The Spaniard has been in charge of Bayer Leverkusen since October 2022. He helped the German side win the Bundesliga ...

Keepin' It Real Sports, a sports management company, posted on X about how the Broncos' offensive line coach reached out to talk with Jacob Bayer II out of Arkansas State. Bayer is a center ...

Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Xabi Alonso Formation: 3 - 5 - 2 Manager: Dieter Hecking Formation: 5 ...

Elliott Management held talks with private equity groups in recent months to gauge interest in buying Bayer’s (BAYRY) consumer health business, as the U.S. hedge fund considered reviving a ...

FRANKFURT, March 26 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China's Puhe ...

Bayer reported that ... The failure of a late-stage study on asundexian was a major setback for the company. In the past 30 days, NVO’s EPS estimate for 2025 has increased to $3.93 from $3 ...

Shares of pharma conglomerate Bayer BAYRY were down 7.1% on March 24, following a setback in the ongoing Roundup Litigation. Bayer reported that, on March 21, the jury at the Barnes Roundup trial ...

Discover for yourself - whether privately or on business - the first-class service at Bayer 04 Leverkusen and become part of the club under the Bayer Cross. Versatile, multifunctional: in the BayArena ...

March 24 (UPI) --A state jury in Georgia directed Bayer, the parent company of Monsanto, to pay more than $2.1 billion in damages to a man who claimed its weed killer Roundup caused his cancer.

Bayer was ordered by a jury in Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said on Friday.